DEPRESSION AND PAIN PERSEVERANCE THROUGH EMPOWERED RECOVERY (DAPPER) PILOT PROGRAM: A CASE STUDY ON TECHNOLOGY
0
Citation
0
Reference
10
Related Paper
Abstract:
Abstract There is a paucity of work focusing on the engagement of older African American women with technology. The aim of the pilot study was to test the Depression and Pain Perseverance through Empowered Recovery (DAPPER) program in a sample of older African American women living with pain and low mood (N=19). The research team hypothesized that most of the women would prefer virtual visits, thus both in-person and virtual options were available for program delivery. So far, of 11 participants, five women have opted to do in-person visits. When asked why, one participant said that having the nurse come to her house was “rewarding, [especially] when you live alone.” Another participant commented that she did not have a computer in her home. These findings demonstrate that older adults exist on a spectrum of comfort with and access to technology.Keywords:
Depression
Sample (material)
Depression
Cite
Citations (0)
Introduction Healthy and at-risk populations Pathophysiology of CVD in individuals with depression Effects of exercise and depression on cardiovascular physiology Structured exercise for the prevention and treatment of depression in apparently healthy individuals Patients with cardiovascular disease Exercise therapy in cardiac patients with depression Exercise prescription for depression Salutary effects of exercise on depression Future directions Conclusion References
Depression
Exercise prescription
Cite
Citations (1)
1. Introduction 2. Epidemiology of Depression in Late Life 3. Economic Burden of Depression in Late Life 4. Biology of Depression in the Elderly 5. Recognition of Depression in Elderly Patients 6. Course of Depression in the Elderly 7. Management of Depression in the Elderly 8. Conclusions 9. References 10. Index
Depression
Management of depression
Late life depression
Cite
Citations (1)
Depression
Cite
Citations (10)
hs-CRP is elevated in depression (1), but evidence on decreases of hs-CRP during depression treatment or the role of hs-CRP in the prediction of response to depression treatment is still controversial (2,3). To date, no study has examined this association in patients with diabetes. As elevated hs-CRP increases the risk of diabetes complications in diabetes (4), we aimed to explore hs-CRP in patients with diabetes and major depression undergoing depression treatment based on the data of the Diabetes and Depression (DAD) study (5).
Participants were randomized to 12 weeks (short-term phase) of diabetes-specific group cognitive behavioral therapy or sertraline treatment and followed up for 15 months (long-term phase). hs-CRP was assessed at baseline and at the end of the long-term phase with a latex-enhanced immunoturbidimetric method. Ethics approval and written informed consent were obtained (5). Information on baseline hs-CRP was available in 219 patients (mean age 48.1 ± 12.0 years, 62% female, mean HbA1c 9.25 ± 1.4% [78 ± 16.2 mmol/mol], 51.6% type 2 diabetes, median hs-CRP 0.33 mg/dL [interquartile range 0.10, 0.84]). Depression outcomes included short-term treatment response (≥50% reduction of the Hamilton Depression Rating Scale [HAMD-17] baseline score or HAMD-17 posttreatment score ≤7), remission of depression at the end of the long-term phase (HAMD-17 scores ≤7 and no …
Depression
Interquartile range
Sertraline
Cite
Citations (15)
Cite
Citations (0)
As the development of more effective treatment options for depression is vital, we investigated the relation between infection/inflammation and depression. Thus, we performed studies using animal models of depression as well as depressive patients. We found that infection in the mouse produced brain changes in proteins regulating the gene expression. The molecules responsible for these changes may be used as a new targets for the treatment of depression. In addition, we found changes in the levels of several genes and proteins within the blood of patients suffering from depressive symptoms, which could be used for a better diagnosis of depression.
Depression
Cite
Citations (0)
Depression in older people is related to the population over 65 years. The age of depression often go with chronic illnesses, various physical and mental diseases. Depression in old age is not a natural part. In the elderly population 1.4% suffered from severe depression. Compared with the rest of the population prevalence of major depression is twice as large in the age group of 70–85 years. Less severe depression have an instance 4–13%. Twice as many women than men have depression. The prevalence of depression is particularly high in the elderly with dementia. In this report we present how many old people in Serbia suffer of depression and what is new tendence in therapy.
Depression
Cite
Citations (1)
Sample (material)
Cite
Citations (1)
Abstract Conflicting results are reported regarding the prevalence of depression in myasthenia gravis (MG) compared to the general population. One suggestion is that the psychiatric instruments used to assess depression confounded symptoms of disease activity with common features of depression. Objectives: We investigated the prevalence of depression in MG using psychiatric instruments that allowed for delineation between a patient's medical and psychological state. Methods: Thirty-six patients with MG and 20 patients with neurologic and neuromuscular diseases (NNMD) were evaluated with 3 self-administered depression scales and a psychiatric interview. Results: Patients with MG had a similar prevalence of depression as that of patients with NNMD. Both groups showed a higher prevalence of depression compared to the general population, which was a frequency similar to a population with chronic illness. No difference was observed between the 2 groups in the physical symptoms of depression. Conclusion: This suggests the physical symptoms of depression do not influence the depression rates in MG when compared to NNMD.
Depression
Prevalence
Cite
Citations (13)